Product NDC: | 0009-0013 |
Proprietary Name: | Solu-Cortef |
Non Proprietary Name: | HYDROCORTISONE SODIUM SUCCINATE |
Active Ingredient(s): | 250 mg/2mL & nbsp; HYDROCORTISONE SODIUM SUCCINATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0013 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA009866 |
Marketing Category: | NDA |
Start Marketing Date: | 19550427 |
Package NDC: | 0009-0013-05 |
Package Description: | 2 mL in 1 VIAL, SINGLE-DOSE (0009-0013-05) |
NDC Code | 0009-0013-05 |
Proprietary Name | Solu-Cortef |
Package Description | 2 mL in 1 VIAL, SINGLE-DOSE (0009-0013-05) |
Product NDC | 0009-0013 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROCORTISONE SODIUM SUCCINATE |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19550427 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | HYDROCORTISONE SODIUM SUCCINATE |
Strength Number | 250 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |